Blue Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Blue Trust's DGX Position: Q3 2026 in Review
Blue Trust reduced its Quest Diagnostics (DGX) stake by 27% in Q3 2026, selling an estimated $67K and leaving 800 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #791.
Blue Trust first reported a position in DGX in Q2 2022 and has held it in 18 quarters since. The position peaked at $326K in Q3 2025. 991 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Blue Trust held 800 shares of Quest Diagnostics worth $186K as of Q3 2026.
- Blue Trust sold 290 Quest Diagnostics shares in Q3 2026, an estimated $67K.
- Quest Diagnostics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #791 holding.
- Blue Trust first reported a position in Quest Diagnostics in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Quest Diagnostics position peaked at $326K in Q3 2025.
- 991 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.